Clinical trials: Albumin
Locally Advanced Unresectable Esophageal Squamous Carcinoma
A Study of Docetaxel for Injection (Albumin-bound) and SG001 in Combination With Cisplatin and Simultaneous Radiotherapy for Locally Advanced Unresectable Esophageal Squamous Carcinoma.
The study is a multicenter, open-label, phase Ib/II study to evaluate the efficacy and safety of docetaxel for injection (albumin-bound) (HB1801) and SG001 in combination with cisplatin and simultaneous radiotherapy versus…
- Trial name
- NCT06136988
- Testing
- Docetaxel for Injection (Albumin-bound), SG001, Cisplatin for injection
- Where
- 2 sites in China
- Volunteers
- 129 people
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Advanced Solid Tumors
Evaluation of the Safety and Efficacy of Albumin-bound Docetaxel
This trial is an open-label, single-center, dose-escalation and cohort-expansion Phase I clinical study in patients with advanced solid tumors.
- Trial name
- NCT04471675
- Testing
- Albumin-bound docetaxel
- Where
- China
- Volunteers
- 208 people
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Metastatic Pancreatic Ductal Adenocarcinoma
Chiauranib Plus PD-1 Inhibitor, Albumin-paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
This is a phase III, multi-center study to evaluate the efficacy and safety of chiauranib plus plus toripalimab, albumin-paclitaxel and gemcitabine as first-line therapy in patients with metastatic pancreatic ductal…
- Trial name
- NCT07445295
- Testing
- Chiauranib, Toripalimab Injection, Albumin-paclitaxel Injection
- Where
- China
- Volunteers
- 558 people
- Sponsor
- Chipscreen Biosciences, Ltd.
Chemotherapy-induced Neutropenia
Neugranin in Breast Cancer Participants Receiving Doxorubicin/Docetaxel
Determination of the effect of neugranin on the duration and severity of severe neutropenia in participants receiving doxorubicin in combination with docetaxel.
- Trial name
- NEUGR-003 (NCT01126190)
- Testing
- Neugranin, Pegfilgrastim, Chemotherapy
- Where
- 59 sites in Bulgaria, Romania and 3 more
- Volunteers
- 381 people
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
Hemophilia A
Study Evaluating ReFacto AF in Severe Hemophilia A
To characterize the safety and efficacy of ReFacto AF in treating acute bleeding episodes during prophylaxis treatment, including neoantigenicity.
- Trial name
- NCT00037544
- Testing
- ReFacto AF
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
Advanced Solid Tumors
A Study of Sirolimus (Albumin-Bound) in Combination With Different ADCs Treatment of Advanced Solid Tumors
This study adopts a multi-center, open-label, non-randomized trial design. It plans to enroll patients with Advanced solid tumor.
- Trial name
- NCT07241936
- Testing
- sirolimus (albumin-bound), DP303c, SYS6043
- Where
- China
- Volunteers
- 444 people
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Microalbuminuria, Hypertension
Management of Albuminuria in Hypertensive Diabetics
Multicenter stepped wedge cluster randomized trial of family practice clinics in Quebec and Ontario comparing the effect of introducing a Point of Care testing (POCT) for urine albumin to usual practice on quality of care in…
- Conditions
- Microalbuminuria, Hypertension, Type 2 Diabetes
- Trial name
- CLINPRADIA (NCT01907958)
- Where
- Canada
- Volunteers
- 280 people
- Sponsor
- Medpharmgene, Inc.